[PHARMA] YoY TTM Result on 30-Sep-2022 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
24-Nov-2022
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2022
Quarter
30-Sep-2022 [#3]
Profit Trend
QoQ- -25.17%
YoY- 52.53%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 3,622,844 3,477,394 3,359,675 4,737,880 2,806,171 2,701,491 2,401,508 7.08%
PBT 158,764 -679,119 182,637 138,481 -189,175 58,549 78,146 12.52%
Tax -59,499 -9,035 -58,325 -58,488 43,758 -24,693 -17,398 22.72%
NP 99,265 -688,154 124,312 79,993 -145,417 33,856 60,748 8.52%
-
NP to SH 96,754 -689,120 122,548 80,344 -144,778 33,816 59,731 8.36%
-
Tax Rate 37.48% - 31.93% 42.24% - 42.17% 22.26% -
Total Cost 3,523,579 4,165,548 3,235,363 4,657,887 2,951,588 2,667,635 2,340,760 7.04%
-
Net Worth -174,968 -245,740 411,327 391,428 345,040 516,387 522,618 -
Dividend
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Div - - 90,356 58,895 26,125 27,347 51,957 -
Div Payout % - - 73.73% 73.30% 0.00% 80.87% 86.99% -
Equity
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Net Worth -174,968 -245,740 411,327 391,428 345,040 516,387 522,618 -
NOSH 1,441,255 1,441,229 1,309,126 1,309,126 261,705 261,229 260,505 32.95%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin 2.74% -19.79% 3.70% 1.69% -5.18% 1.25% 2.53% -
ROE 0.00% 0.00% 29.79% 20.53% -41.96% 6.55% 11.43% -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
RPS 251.37 258.96 256.47 361.91 1,073.54 1,035.84 923.62 -19.48%
EPS 6.71 -51.32 9.36 6.14 -55.39 12.97 22.97 -18.52%
DPS 0.00 0.00 6.90 4.50 10.00 10.50 20.00 -
NAPS -0.1214 -0.183 0.314 0.299 1.32 1.98 2.01 -
Adjusted Per Share Value based on latest NOSH - 1,309,126
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
RPS 251.37 241.28 233.11 328.73 194.70 187.44 166.63 7.08%
EPS 6.71 -47.81 8.50 5.57 -10.05 2.35 4.14 8.37%
DPS 0.00 0.00 6.27 4.09 1.81 1.90 3.61 -
NAPS -0.1214 -0.1705 0.2854 0.2716 0.2394 0.3583 0.3626 -
Price Multiplier on Financial Quarter End Date
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Date 30/09/24 29/09/23 30/09/22 30/09/21 30/09/20 30/09/19 28/09/18 -
Price 0.39 0.435 0.515 0.835 4.32 2.44 2.89 -
P/RPS 0.16 0.17 0.20 0.23 0.40 0.24 0.31 -10.42%
P/EPS 5.81 -0.85 5.51 13.61 -7.80 18.82 12.58 -12.07%
EY 17.21 -117.97 18.17 7.35 -12.82 5.31 7.95 13.72%
DY 0.00 0.00 13.40 5.39 2.31 4.30 6.92 -
P/NAPS 0.00 0.00 1.64 2.79 3.27 1.23 1.44 -
Price Multiplier on Announcement Date
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Date 26/11/24 29/11/23 24/11/22 19/11/21 19/11/20 20/11/19 19/11/18 -
Price 0.355 0.405 0.55 0.845 5.72 2.21 3.09 -
P/RPS 0.14 0.16 0.21 0.23 0.53 0.21 0.33 -13.30%
P/EPS 5.29 -0.79 5.88 13.77 -10.33 17.04 13.45 -14.39%
EY 18.91 -126.71 17.01 7.26 -9.68 5.87 7.43 16.83%
DY 0.00 0.00 12.55 5.32 1.75 4.75 6.47 -
P/NAPS 0.00 0.00 1.75 2.83 4.33 1.12 1.54 -

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment